Development
Bristol-Myers Squibb Company
BMY
$48.44
$0.631.32%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
--
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -2.50% | -3.86% | -4.15% | -2.37% | -0.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.50% | -3.86% | -4.15% | -2.37% | -0.49% |
| Cost of Revenue | 7.54% | 7.42% | 5.91% | 5.81% | 4.76% |
| Gross Profit | -5.20% | -6.78% | -6.70% | -4.40% | -1.81% |
| SG&A Expenses | -0.42% | 1.05% | 0.80% | -2.20% | 0.67% |
| Depreciation & Amortization | -5.71% | -5.76% | -5.34% | -4.97% | -4.27% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.45% | 0.75% | 0.29% | -0.06% | -0.23% |
| Operating Income | -13.33% | -19.84% | -19.16% | -10.27% | -1.41% |
| Income Before Tax | 9.43% | 11.84% | 13.54% | 21.24% | -4.75% |
| Income Tax Expenses | -70.76% | -68.43% | -29.69% | 48.63% | 26.20% |
| Earnings from Continuing Operations | 26.71% | 24.07% | 20.21% | 16.93% | -9.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 16.67% | -20.00% | 26.32% | -5.88% | 10.00% |
| Net Income | 26.84% | 24.08% | 20.34% | 16.96% | -9.54% |
| EBIT | -13.33% | -19.84% | -19.16% | -10.27% | -1.41% |
| EBITDA | -9.08% | -13.13% | -12.35% | -7.87% | -2.97% |
| EPS Basic | 30.29% | 28.23% | 24.53% | 21.56% | -5.64% |
| Normalized Basic EPS | -3.05% | -11.16% | -9.77% | -2.56% | 3.46% |
| EPS Diluted | 30.65% | 28.20% | 24.78% | 21.49% | -5.53% |
| Normalized Diluted EPS | -2.74% | -10.96% | -9.57% | -2.33% | 3.76% |
| Average Basic Shares Outstanding | -2.86% | -2.98% | -3.07% | -3.65% | -4.10% |
| Average Diluted Shares Outstanding | -3.18% | -3.19% | -3.28% | -3.87% | -4.39% |
| Dividend Per Share | 5.48% | 5.56% | 6.64% | 7.77% | 8.96% |
| Payout Ratio | -0.19% | -0.17% | -0.14% | -0.11% | 0.17% |